PepTcell Announces New Flu Vaccine

PepTcell (High Wycombe, UK, www.peptcell.com) recently released preclinical data indication that Flu-V, its new flu vaccine, has the potential to protect against both pandemic and seasonal strains of influenza. The data was presented by PepTcell, at the 2007 Options for the Control of Influenza VI Conference, in Toronto, Canada. Flu-V, a single-treatment flu vaccine, is about to enter clinical trials in the UK. The vaccine, if proven to be effective against all strains of flu virus, could eliminate the need for annual flu vaccinations.